world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Gastroenterology, 118(2 Suppl 1): S115-28, with the permission<br />
of W.B. Saunders Company<br />
4.27 IARCPress<br />
4.28 B. Marincek, Institut für Diagnostische Radiologie,<br />
UniversitätsSpital, Ramistrasse 100, CH-8091 Zürich,<br />
Switzerland<br />
4.29 R. Sankaranarayanan, IARC<br />
4.30 Copyright GE Medical Systems<br />
4.31 P. Pisani, IARC<br />
4.32 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
4.33 A. M. Thompson, UK<br />
4.34 Wellcome Trust Medical Photographic Library, UK<br />
4.35 Graphics and Audiovisual section, NCI Office of Cancer<br />
Communications, USA<br />
4.36 Reprinted from Radiol Clin North Am, 38, L. Tabar, B.<br />
Vitak, H.H. Chen, S.W. Duffy, M.F. Yen et al., The Swedish<br />
Two-County Trial twenty years later. Updated mortality<br />
results and new insights from long-term follow-up, 625-<br />
651, copyright (2000), with permission from Elsevier Science<br />
4.37 Wellcome Trust Medical Photographic Library, UK<br />
4.38 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
4.39 R. LiPuma, Prostate Cancer Education Council, 300 South<br />
Jackson Street, Suite 540 Denver, CO 80209, USA.<br />
4.40 C.A. Rubio, Gastrointestinal and Liver Pathology,<br />
Department of Pathology, Karolinska Institute, 171 76<br />
Stockholm, Sweden<br />
4.41 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
4.42 Prévention et Biologie, SA, 29-33 Rue de Metz, 94170<br />
Le Perreux, France<br />
4.43 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
4.44 IARCPress<br />
4.45 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
4.46 Adapted from M.R. Law, J.K. Morris, N.J. Wald (1999) The<br />
importance of age in screening for <strong>cancer</strong>. J Med Screen,<br />
6(1): 16-20, with permission from the BMJ Publishing Group<br />
4.47 R. Sankaranarayanan, IARC<br />
4.48 IARCPress<br />
4.49 - 4.52 R. Sankaranarayanan, IARC<br />
4.53 A & B H. Ohgaki, IARC<br />
4.53C R. Lambert, IARC<br />
4.54 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
4.55 Adapted from Table 2, Y. Tsubono and S. Hisamichi (2000)<br />
Screening for gastric <strong>cancer</strong> in Japan. Gastric <strong>cancer</strong>,<br />
3: 9-18. Copyright Springer-Verlag<br />
5.1 GLOBOCAN 2000*<br />
5.2 Graphics and Audiovisual section, NCI Office of Cancer<br />
Communications, USA<br />
5.3 B.W. Stewart, Australia<br />
5.4 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
5.5 J.A. Baron and T.E. Rohan, Tobacco, in D. Schottenfeld and<br />
J.F. Fraumeni Jr. eds (1996) Cancer Epidemiology and<br />
Prevention, 2nd edition, Oxford University Press, UK<br />
5.6 P. Boffetta, IARC/Adapted from J.H. Lubin, W.J. Blot<br />
(1984) Assessment of lung <strong>cancer</strong> risk factors by histo-<br />
338 Sources of figures and tables<br />
logic category. J Natl Cancer Inst, 73: 383-389<br />
5.7 B. Marincek, Institut für Diagnostische Radiologie,<br />
UniversitätsSpital, Ramistrasse 100, CH-8091 Zurich,<br />
Switzerland<br />
5.8 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-<br />
Pathologie, Hôpital Edouard Herriot, Place d’Arsonval,<br />
69437 Lyon France<br />
5.9 P. Boffetta, IARC<br />
5.10 IARC/SEER/Osaka Cancer Registry†<br />
5.11 IARCPress/Department of Pathology, University of<br />
Zurich, Switzerland<br />
5.12 GLOBOCAN 2000*<br />
5.13 Wellcome Trust Medical Photographic Library, UK<br />
5.14 Von Kantor & Associates Inc., Ft. Lauderdale FL,<br />
USA/www.lectureslides.com<br />
5.15 A. M. Thompson, UK<br />
5.16 & 5.17 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-<br />
Pathologie, Hôpital Edouard Herriot, Place d’Arsonval,<br />
69437 Lyon France<br />
5.18 P. Kleihues, IARC<br />
5.19 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
5.20 Von Kantor & Associates Inc., Ft. Lauderdale FL,<br />
USA/www.lectureslides.com<br />
5.21 IARC/SEER/Osaka Cancer Registry†<br />
5.22 IARCPress<br />
5.23 GLOBOCAN 2000*<br />
5.24 D.M. Parkin et al. (2001) Eur J Cancer, 37, suppl.8: S4-66<br />
5.25 N. Matsukura, Japan<br />
5.26 H. Ohgaki, IARC<br />
5.27 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-<br />
Pathologie, Hôpital Edouard Herriot, Place d’Arsonval,<br />
69437 Lyon France<br />
5.28 IARC/SEER/Osaka Cancer Registry†<br />
5.29 GLOBOCAN 2000*<br />
5.30 IARCPress<br />
5.31 Reprinted from European Journal of Cancer, Vol 35, No 3,<br />
Ilyas M, Straub J, Tomlinson IPM, Bodmer W, Genetic pathways<br />
in colorectal and other <strong>cancer</strong>s, 335-351, copyright<br />
(1999), with permission from Elsevier Science<br />
5.32 - 5.34 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-<br />
Pathologie, Hôpital Edouard Herriot, Place d’Arsonval,<br />
69437 Lyon France<br />
5. 35 C. Fenoglio-Preiser, Department of Pathology, University<br />
of Cincinnati, School of Medicine, 231 Bethesda Avenue,<br />
POB 670529, Cincinnati, OH 45267-0529, USA<br />
5.36 IARC/SEER/Osaka Cancer Registry†<br />
5.37 & 5.38 GLOBOCAN 2000*<br />
5.39 IARCPress<br />
5.40 B. Marincek, Institut für Diagnostische Radiologie,<br />
UniversitätsSpital, Ramistrasse 100, CH-8091 Zurich,<br />
Switzerland<br />
5.41 - 5.43 F. Berger and J.Y. Scoazec, Laboratoire d’Anatomo-<br />
Pathologie, Hôpital Herriot, place d’arsonval, 69437 Lyon